Nuvectis Pharma, Inc. (NVCT) Misses Q2 EPS by 5c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q2 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
• Karman Holdings stock falls after short-seller questions cash flow